Series A financing at Scenic Biotech to support immuno-oncology and rare inherited disease pipeline March 10, 2022 No Comments
Novel UV-mediated antigen-presenting nanoparticles for mRNA delivery to virus-specific T cells March 7, 2022 No Comments
Researchers present novel capsule-mediated gastrointestinal mRNA delivery approach Feb. 8, 2022 No Comments
eTheRNA and Merck KGaA sign research agreement to assess mRNA technology for therapeutic vaccination Feb. 7, 2022 No Comments
Engineered virus-like particles for in vivo delivery of gene editing proteins Jan. 24, 2022 No Comments
RSS